Sponsored message
Logged in as
Audience-funded nonprofit news
radio tower icon laist logo
Next Up:
0:00
0:00
Subscribe
  • Listen Now Playing Listen
  • Listen Now Playing Listen
AirTalk

Slick new public health campaign targets kid-friendly e-cigarettes

This Aug. 14, 2014 photo shows child-proof refill bottles of liquid nicotine at Salt Lake Vapors, in Salt Lake City. Poison control workers say that as the e-cigarette industry has boomed, the number of children exposed to the liquid nicotine that gives hand-held vaporizing gadgets their kick also is spiking. The American Association of Poison Control Centers reports that more than 2,700 people have called about a liquid nicotine exposure this year, up from a few hundred cases three years ago. (AP Photo/Rick Bowmer)
This Aug. 14, 2014 photo shows child-proof refill bottles of liquid nicotine at Salt Lake Vapors, in Salt Lake City. Poison control workers say that as the e-cigarette industry has boomed, the number of children exposed to the liquid nicotine that gives hand-held vaporizing gadgets their kick also is spiking.
(
Rick Bowmer/AP
)
Listen 17:53
Slick new public health campaign targets kid-friendly e-cigarettes

The California Department of Health’s ad campaign launched yesterday is its latest move against the e-cigarette industry. The 30-second TV spots will be broadcast through June in efforts to shed light on misleading information about the health threats linked to e-cigarettes.

A January report released by the department shows the harmful effects of the e-liquid found in e-cigarettes that is often inaccurately labeled. Not to mention the industry’s blatant advertising geared toward youth, which has seen an uptick in e-cigarette use.

Will this ad campaign deter you or someone you know from using e-cigarettes? Has using e-cigarettes helped you cut back from traditional ones?

Read the full story here

Dr. Michael Ong,  professor at the David Geffen School of Medicine , UCLA

Mark Kleiman, Professor of Public Policy at UCLA School of Public Affairs and the editor of the Journal of Drug Policy Analysis; Kleiman also does research into tax-policy impacts for tobacco maker Altria Group